Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas

NCT00001165 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

999

Enrollment

NIH

Sponsor class

Conditions

Islet Cell Adenoma
Neoplasm Metastasis
Zollinger Ellison Syndrome

Interventions

DRUG: combined chemotherapy with streptozotocin, 5-fluorouracil, and doxorubicin

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)